Compare KDP & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KDP | BDX |
|---|---|---|
| Founded | 1981 | 1897 |
| Country | United States | United States |
| Employees | N/A | 72000 |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0B | 40.3B |
| IPO Year | 2007 | 1997 |
| Metric | KDP | BDX |
|---|---|---|
| Price | $31.57 | $146.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $32.27 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 10.4M | 2.3M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.18% | 2.89% |
| EPS Growth | ★ 45.71 | N/A |
| EPS | 0.20 | ★ 0.25 |
| Revenue | $16,603,000,000.00 | ★ $21,840,000,000.00 |
| Revenue This Year | $58.73 | N/A |
| Revenue Next Year | $14.29 | $3.02 |
| P/E Ratio | ★ $156.13 | $589.64 |
| Revenue Growth | 8.16 | ★ 8.24 |
| 52 Week Low | $24.88 | $141.82 |
| 52 Week High | $35.94 | $213.08 |
| Indicator | KDP | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 69.06 | 46.05 |
| Support Level | $26.61 | $142.48 |
| Resistance Level | $31.50 | $153.09 |
| Average True Range (ATR) | 0.72 | 3.25 |
| MACD | 0.09 | 0.33 |
| Stochastic Oscillator | 75.80 | 33.43 |
Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. On Aug. 25, 2025, the firm announced a definitive agreement to acquire coffeemaker JDE Peet's for $18 billion in cash, with the deal now scheduled to close in April 2026. Following the merger, it plans to split into two US-listed entities to focus on refreshment beverages in North America and global coffee separately.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.